Interleukin-4	B-protein
inhibits	O
the	O
lipopolysaccharide-induced	O
expression	O
of	O
c-jun	B-RNA
and	I-RNA
c-fos	I-RNA
messenger	I-RNA
RNA	I-RNA
and	O
activator	B-protein
protein-1	I-protein
binding	O
activity	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

We	O
studied	O
the	O
effect	O
of	O
interleukin-4	B-protein
(	O
IL-4	B-protein
)	O
on	O
the	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induction	O
of	O
two	O
immediate	O
early	O
genes	O
c-fos	B-DNA
and	O
c-jun	B-DNA
.	O

These	O
genes	O
encode	O
proteins	O
that	O
form	O
the	O
dimeric	B-protein
complex	I-protein
activator	B-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
,	O
which	O
is	O
active	O
as	O
a	O
transcriptional	B-protein
factor	I-protein
.	O

Maximal	O
accumulation	O
of	O
either	O
c-fos	B-RNA
and	I-RNA
c-jun	I-RNA
messenger	I-RNA
RNA	I-RNA
(	O
mRNA	O
)	O
occurred	O
30	O
minutes	O
after	O
LPS	O
addition	O
.	O

When	O
cells	O
were	O
treated	O
with	O
IL-4	B-protein
for	O
5	O
hours	O
before	O
LPS	O
activation	O
,	O
both	O
the	O
c-fos	O
and	O
the	O
c-jun	O
mRNA	O
expression	O
was	O
decreased	O
.	O

The	O
inhibition	O
of	O
c-fos	B-DNA
and	O
c-jun	O
expression	O
by	O
IL-4	B-protein
in	O
LPS-treated	B-cell_type
cells	I-cell_type
was	O
shown	O
to	O
be	O
due	O
to	O
a	O
lower	O
transcription	O
rate	O
of	O
the	O
c-fos	B-DNA
and	I-DNA
c-jun	I-DNA
genes	I-DNA
.	O

IL-4	B-protein
did	O
not	O
affect	O
the	O
stability	O
of	O
the	O
c-fos	B-protein
and	O
c-jun	B-protein
transcripts	I-protein
.	O

Finally	O
,	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
evidence	O
was	O
obtained	O
that	O
IL-4	B-protein
inhibits	O
LPS-induced	O
expression	O
of	O
AP-1	B-protein
protein	O
.	O

These	O
data	O
indicate	O
that	O
IL-4	B-protein
suppresses	O
the	O
induction	O
of	O
transcription	B-protein
factors	I-protein
in	O
human	B-cell_type
activated	I-cell_type
monocytes	I-cell_type
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Interleukin-4	NULL
Inhibits	NULL
the	NULL
Lipopolysaccharide-Induced	NULL
Expression	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
Messenger	NULL
RNA	NULL
and	NULL
Activator	NULL
Protein-1	NULL
Binding	NULL
Activity	NULL
in	NULL
Human	NULL
Monocytes	NULL
By	NULL
Willem	NULL
H.A	NULL
.	NULL

Dokter	NULL
,	NULL
Mariet	NULL
T.	NULL
Esselink	NULL
,	NULL
M.	NULL
Ruud	NULL
Halie	NULL
,	NULL
and	NULL
Edo	NULL
Vellenga	NULL
We	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
on	NULL
the	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
induction	NULL
of	NULL
two	NULL
immediate	NULL
early	NULL
genes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
.	NULL

These	NULL
genes	NULL
encode	NULL
proteins	NULL
that	NULL
form	NULL
the	NULL
dimeric	NULL
complex	NULL
activator	NULL
protein-1	NULL
{	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
which	NULL
is	NULL
active	NULL
as	NULL
a	NULL
transcriptional	NULL
factor	NULL
.	NULL

Maximal	NULL
accumulation	NULL
of	NULL
either	NULL
c-fos	NULL
and	NULL
c-jun	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
occurred	NULL
30	NULL
minutes	NULL
after	NULL
LPS	NULL
addition	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-4	NULL
for	NULL
5	NULL
hours	NULL
before	NULL
LPS	NULL
activation	NULL
,	NULL
both	NULL
the	NULL
c-fos	NULL
and	NULL
the	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
was	NULL
decreased	NULL
.	NULL

The	NULL
inhi-	NULL
NTERLEUKIN-4	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
a	NULL
product	NULL
of	NULL
activated	NULL
T	NULL
lym-phocytes	NULL
,	NULL
``	NULL
affects	NULL
,	NULL
among	NULL
others	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
haematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

**	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-4	NULL
inhibits	NULL
the	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-induced	NULL
expression	NULL
of	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNFa	NULL
)	NULL
,	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
in	NULL
monocytes	NULL
and	NULL
the	NULL
secretion	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL
``	NULL

The	NULL
common	NULL
feature	NULL
in	NULL
these	NULL
studies	NULL
was	NULL
a	NULL
suppressive	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
cytokine	NULL
expression	NULL
,	NULL
whereby	NULL
IL-4	NULL
by	NULL
itself	NULL
does	NULL
not	NULL
induce	NULL
cytokine	NULL
expression	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
is	NULL
a	NULL
heterodimer	NULL
formed	NULL
by	NULL
a	NULL
product	NULL
of	NULL
the	NULL
Fos	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
genes	NULL
c-fos	NULL
,	NULL
fra-1	NULL
,	NULL
fra-2	NULL
,	NULL
and	NULL
fos	NULL
B	NULL
,	NULL
and	NULL
a	NULL
product	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
genes	NULL
c-jun	NULL
,	NULL
junB	NULL
,	NULL
and	NULL
junD	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
A	NULL
homodimer	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
for	NULL
the	NULL
AP-1-binding	NULL
sequence	NULL
can	NULL
be	NULL
formed	NULL
by	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
.	NULL

AP-1	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
cytokine	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
It	NULL
recognizes	NULL
the	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
with	NULL
the	NULL
target	NULL
sequence	NULL
TGACTCA	NULL
,	NULL
**	NULL
``	NULL
which	NULL
is	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
IL-4	NULL
also	NULL
affects	NULL
the	NULL
expression	NULL
of	NULL
AP-1	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-4	NULL
inhibits	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
,	NULL
which	NULL
could	NULL
be	NULL
ascribed	NULL
to	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcription	NULL
rate	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-4	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
LPS-induced	NULL
AP-1	NULL
protein	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
of	NULL
cells	NULL
.	NULL

-	NULL
Peripheral	NULL
blood	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
volunteer	NULL
platelet	NULL
donors	NULL
and	NULL
mononuclear	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
by	NULL
Ficoll-Hypaque	NULL
density-gradient	NULL
centrifugation	NULL
.	NULL

T	NULL
lym-phocytes	NULL
were	NULL
removed	NULL
by	NULL
2-aminoethylisothiouronium	NULL
bromide	NULL
(	NULL
AET	NULL
)	NULL
-treated	NULL
sheep	NULL
red	NULL
blood	NULL
cell	NULL
rosetting	NULL
.	NULL

Monocytes	NULL
were	NULL
further	NULL
enriched	NULL
by	NULL
plastic	NULL
adherence	NULL
(	NULL
1	NULL
hour	NULL
at	NULL
37°C	NULL
)	NULL
and	NULL
demonstrated	NULL
a	NULL
purity	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
as	NULL
detected	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
with	NULL
CD14	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10°/mL	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
(	NULL
Flow	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
without	NULL
serum	NULL
,	NULL
supplemented	NULL
with	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
100	NULL
ug/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
.	NULL

Before	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
described	NULL
medium	NULL
for	NULL
16	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
for	NULL
various	NULL
time	NULL
periods	NULL
with	NULL
1	NULL
ug/	NULL
mL	NULL
LPS	NULL
(	NULL
Pseudomonas	NULL
aeruginosa	NULL
,	NULL
serotype	NULL
10	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
with	NULL
15	NULL
ng/mL	NULL
human	NULL
recombinant	NULL
IL-4	NULL
(	NULL
gift	NULL
of	NULL
Dr	NULL
P.	NULL
Trotta	NULL
,	NULL
Schering	NULL
Plough	NULL
,	NULL
Bloomfield	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
or	NULL
with	NULL
1	NULL
ug/mL	NULL
LPS	NULL
after	NULL
5	NULL
hours	NULL
Blood	NULL
,	NULL
Vol	NULL
81	NULL
,	NULL
No	NULL
2	NULL
(	NULL
January	NULL
15	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
337-343	NULL
bition	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
by	NULL
IL-4	NULL
in	NULL
LPS-treated	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
due	NULL
to	NULL
a	NULL
lower	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
.	NULL

IL-4	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
.	NULL

Finally	NULL
,	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
evidence	NULL
was	NULL
obtained	NULL
that	NULL
IL-4	NULL
inhibits	NULL
LPS-induced	NULL
expression	NULL
of	NULL
AP-1	NULL
protein	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
IL-4	NULL
suppresses	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
activated	NULL
monocytes	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

of	NULL
incubation	NULL
with	NULL
15	NULL
ng/mL	NULL
IL-4	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
of	NULL
IL-4	NULL
was	NULL
10	NULL
``	NULL
U/mg	NULL
.	NULL

The	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
gmol/L	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
ActD	NULL
;	NULL
Boeh-ringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/	NULL
mL	NULL
.	NULL

mRNA	NULL
extraction	NULL
and	NULL
analysis	NULL
.	NULL

-	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidium	NULL
isothiocyanate/CsCl	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Nine	NULL
micrograms	NULL
total	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
in	NULL
2.2	NULL
mol/L	NULL
formaldehyde	NULL
,	NULL
1.1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond	NULL
N+	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
following	NULL
cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
by	NULL
the	NULL
random	NULL
hexamer	NULL
priming	NULL
method	NULL
``	NULL
``	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
0.9-kb	NULL
Neo	NULL
I/Sca	NULL
I	NULL
insert	NULL
containing	NULL
exons	NULL
3	NULL
and	NULL
4	NULL
of	NULL
a	NULL
human	NULL
c-fos	NULL
DNA	NULL
purified	NULL
from	NULL
the	NULL
pc-fos	NULL
plasmid	NULL
``	NULL
*	NULL
``	NULL
``	NULL
;	NULL
(	NULL
2	NULL
)	NULL
the	NULL
1.2-kb	NULL
EcoRI/BamHI	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-jun	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pe-jun	NULL
plasmid	NULL
``	NULL
(	NULL
both	NULL
plasmids	NULL
are	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
R.	NULL
Henschler	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
;	NULL
(	NULL
3	NULL
)	NULL
the	NULL
EcoRI	NULL
linearized	NULL
pBR	NULL
322	NULL
plasmid	NULL
containing	NULL
a	NULL
7.8-kb	NULL
human	NULL
28	NULL
$	NULL
DNA	NULL
insert	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
65°C	NULL
for	NULL
18	NULL
hours	NULL
in	NULL
0.5	NULL
mol/L	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
once	NULL
in	NULL
1	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
finally	NULL
in	NULL
0.3	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
65°C	NULL
.	NULL

Hybridization	NULL
was	NULL
made	NULL
visible	NULL
by	NULL
exposure	NULL
of	NULL
the	NULL
membranes	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
XAR	NULL
films	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Roch-ester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-80°C	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Quantification	NULL
of	NULL
mRNA	NULL
levels	NULL
was	NULL
performed	NULL
by	NULL
densitometry	NULL
using	NULL
a	NULL
Gel	NULL
Scan	NULL
laser	NULL
densitometer	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Values	NULL
were	NULL
corrected	NULL
for	NULL
differences	NULL
in	NULL
gel	NULL
loading	NULL
by	NULL
normalization	NULL
to	NULL
the	NULL
respective	NULL
288	NULL
signals	NULL
.	NULL

Run	NULL
on	NULL
transcription	NULL
assay	NULL
.	NULL

-	NULL
For	NULL
the	NULL
nuclear	NULL
run	NULL
on	NULL
assay	NULL
,	NULL
monocytes	NULL
of	NULL
four	NULL
donors	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
hours	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10°	NULL
cells/mL	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
careful	NULL
use	NULL
of	NULL
a	NULL
rubber	NULL
policeman	NULL
and	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
pelleted	NULL
separately	NULL
for	NULL
each	NULL
donor	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
phos-phate-buffered	NULL
saline	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
4	NULL
mL	NULL
of	NULL
lysis-buffer	NULL
(	NULL
10	NULL
mmol/	NULL
L	NULL
Tris-HCL	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
3	NULL
mmol/L	NULL
MgCl	NULL
)	NULL
;	NULL
,	NULL
10	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
NP	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Submitted	NULL
July	NULL
7	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
September	NULL
11	NULL
,	NULL
1992	NULL
.	NULL

EV	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Royal	NULL
Netherlands	NULL
Academy	NULL
of	NULL
Arts	NULL
and	NULL
Sciences	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Edo	NULL
Vellenga	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
Hospital	NULL
,	NULL
Oostersingel	NULL
59	NULL
,	NULL
9713	NULL
EZ	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/93/8102-0006	NULL
$	NULL
3.00/0	NULL
337	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

338	NULL
40	NULL
)	NULL
.	NULL

After	NULL
gentle	NULL
vortexing	NULL
,	NULL
the	NULL
suspension	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
500g	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
the	NULL
above	NULL
described	NULL
lysis	NULL
was	NULL
repeated	NULL
.	NULL

The	NULL
nuclei	NULL
of	NULL
four	NULL
donors	NULL
were	NULL
pooled	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
LL	NULL
glycerol-buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
26°C	NULL
for	NULL
20	NULL
minutes	NULL
with	NULL
80	NULL
gL	NULL
transcription-buffer	NULL
(	NULL
12.5	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
6	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
125	NULL
mmol/L	NULL
KCI	NULL
,	NULL
2	NULL
mmol/L	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mmol/L	NULL
each	NULL
of	NULL
ATP	NULL
,	NULL
CTP	NULL
,	NULL
and	NULL
GTP	NULL
)	NULL
and	NULL
12.5	NULL
LL	NULL
[	NULL
aP	NULL
]	NULL
UTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

Transcription	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
40	NULL
U	NULL
DNAse	NULL
I	NULL
,	NULL
150	NULL
U	NULL
RNAsin	NULL
,	NULL
40	NULL
ug	NULL
yeast	NULL
RNA	NULL
,	NULL
and	NULL
200	NULL
LL	NULL
stop-buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.5	NULL
mol/L	NULL
NaCl	NULL
,	NULL
50	NULL
mmol/L	NULL
MgC1	NULL
;	NULL
,	NULL
2	NULL
mmol/L	NULL
CaCl	NULL
)	NULL
;	NULL
)	NULL
.	NULL

The	NULL
solution	NULL
was	NULL
then	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

After	NULL
a	NULL
proteinase	NULL
K	NULL
digestion	NULL
(	NULL
750	NULL
U	NULL
proteinase	NULL
K/mL	NULL
)	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
the	NULL
nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
phenol-chloroform	NULL
extractions	NULL
and	NULL
then	NULL
ethanol	NULL
precipitated	NULL
two	NULL
times	NULL
in	NULL
2.5	NULL
mol/L	NULL
ammonium	NULL
acetate	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
Sephadex	NULL
G-50	NULL
column	NULL
separation	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
the	NULL
following	NULL
DNAs	NULL
were	NULL
immobilized	NULL
on	NULL
Hybond	NULL
N+	NULL
membranes	NULL
:	NULL
(	NULL
1	NULL
)	NULL
EcoRI	NULL
linearized	NULL
pBR322	NULL
;	NULL
(	NULL
2	NULL
)	NULL
Xho	NULL
I	NULL
linearized	NULL
pc-fos	NULL
containing	NULL
a	NULL
3.1-kb	NULL
fragment	NULL
of	NULL
all	NULL
4	NULL
human	NULL
c-fos	NULL
exons	NULL
``	NULL
*	NULL
``	NULL
``	NULL
;	NULL
(	NULL
3	NULL
)	NULL
EcoRI	NULL
linearized	NULL
pe-jun	NULL
containing	NULL
a	NULL
1.2-kb	NULL
fragment	NULL
of	NULL
human	NULL
c-jun	NULL
cDNA	NULL
``	NULL
;	NULL
(	NULL
4	NULL
)	NULL
EcoRI	NULL
linearized	NULL
plasmid	NULL
containing	NULL
a	NULL
7.8-kb	NULL
human	NULL
28	NULL
$	NULL
DNA	NULL
.	NULL

Hybridization	NULL
of	NULL
labeled	NULL
RNA	NULL
to	NULL
these	NULL
membranes	NULL
was	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Washing	NULL
was	NULL
as	NULL
described	NULL
above	NULL
except	NULL
that	NULL
an	NULL
extra	NULL
wash-step	NULL
with	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
1	NULL
ug/mL	NULL
RNase	NULL
A	NULL
(	NULL
Boehringer	NULL
)	NULL
was	NULL
included	NULL
.	NULL

Exposure	NULL
and	NULL
quantification	NULL
of	NULL
transcription	NULL
rate	NULL
levels	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Transcription	NULL
rates	NULL
were	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
288	NULL
signal	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

-	NULL
After	NULL
stimulation	NULL
for	NULL
various	NULL
time	NULL
periods	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
miniscale	NULL
procedure	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Nuclear	NULL
extracts	NULL
were	NULL
divided	NULL
in	NULL
small	NULL
aliquots	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
N	NULL
;	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

-	NULL
The	NULL
AP-1	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
was	NULL
obtained	NULL
by	NULL
annealing	NULL
synthetic	NULL
oligonu-cleotides	NULL
:	NULL
5°-AGCTCGCGTGACTCAGCTG-3	NULL
'	NULL
3'-GCGCACTGAGTCGACCTAG-5	NULL
'	NULL
The	NULL
consensus	NULL
sequence	NULL
for	NULL
binding	NULL
of	NULL
AP-1	NULL
is	NULL
underlined	NULL
.	NULL

Fifty	NULL
nanograms	NULL
of	NULL
high	NULL
performance	NULL
liquid	NULL
chromatography	NULL
(	NULL
HPLC	NULL
)	NULL
-purified	NULL
single-stranded	NULL
oligonucleotide	NULL
was	NULL
labeled	NULL
with	NULL
T4-polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
7P	NULL
]	NULL
ATP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
}	NULL
,	NULL
separated	NULL
from	NULL
nonincorporated	NULL
radiolabel	NULL
by	NULL
sephadex	NULL
G50	NULL
chro-matography	NULL
,	NULL
ethanol	NULL
precipitated	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
dissolved	NULL
in	NULL
20	NULL
kL	NULL
of	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
/50	NULL
mmol/L	NULL
mmol/L	NULL
MgCly/	NULL
1	NULL
mmol/L	NULL
EDTA/1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
containing	NULL
a	NULL
fourfold	NULL
excess	NULL
of	NULL
the	NULL
opposite	NULL
strand	NULL
.	NULL

Annealing	NULL
of	NULL
the	NULL
two	NULL
strands	NULL
was	NULL
performed	NULL
by	NULL
heating	NULL
the	NULL
mixture	NULL
for	NULL
2	NULL
minutes	NULL
at	NULL
90°C	NULL
and	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

Reannealed	NULL
DNA	NULL
corresponding	NULL
to	NULL
0.1	NULL
ng	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
0.4	NULL
ng	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
3	NULL
ug	NULL
nuclear	NULL
extract	NULL
in	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
60	NULL
mmol/L	NULL
KCl	NULL
,	NULL
0.06	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.6	NULL
mmol/L	NULL
DTT	NULL
,	NULL
2	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
supplemented	NULL
with	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
preincubated	NULL
for	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
before	NULL
adding	NULL
the	NULL
labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
at	NULL
26°C	NULL
for	NULL
25	NULL
minutes	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
self	NULL
or	NULL
nonself	NULL
oligonucleotides	NULL
before	NULL
preincubation	NULL
on	NULL
ice	NULL
.	NULL

An	NULL
oligonucleotide	NULL
with	NULL
the	NULL
sequence	NULL
:	NULL
5-AGCTGCCGGGATTTTCCCTG-3	NULL
3-CGCCCCTAAAAGGGACCTAG-	NULL
5	NULL
DOKTER	NULL
ET	NULL
AL	NULL
spanning	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
recognition	NULL
site	NULL
``	NULL
``	NULL
(	NULL
under-lined	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
the	NULL
nonself	NULL
oligo	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
loaded	NULL
on	NULL
prerunned	NULL
(	NULL
30	NULL
minutes	NULL
at	NULL
100	NULL
V	NULL
)	NULL
4	NULL
%	NULL
(	NULL
30:1	NULL
)	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
run	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
150	NULL
V	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
films	NULL
at	NULL
-80°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

The	NULL
same	NULL
batches	NULL
of	NULL
proteins	NULL
and	NULL
labeled	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
the	NULL
reactions	NULL
presented	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

RESULTS	NULL
In	NULL
accordance	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
``	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
isolated	NULL
immediately	NULL
after	NULL
plastic	NULL
adherence	NULL
for	NULL
1	NULL
hour	NULL
demonstrated	NULL
a	NULL
high	NULL
expression	NULL
of	NULL
c-fos	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
after	NULL
a	NULL
16-hour	NULL
incubation	NULL
period	NULL
in	NULL
serum-free	NULL
medium	NULL
,	NULL
a	NULL
low	NULL
expression	NULL
of	NULL
c-fos	NULL
mRNA	NULL
was	NULL
noticed	NULL
.	NULL

Therefore	NULL
,	NULL
monocytes	NULL
were	NULL
treated	NULL
after	NULL
a	NULL
16-hour	NULL
incubation	NULL
period	NULL
in	NULL
serum-free	NULL
medium	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-4	NULL
pretreatment	NULL
on	NULL
the	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
was	NULL
studied	NULL
.	NULL

This	NULL
sequential	NULL
treatment	NULL
was	NULL
chosen	NULL
because	NULL
the	NULL
most	NULL
pronounced	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
G-CSF	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
stimulation	NULL
was	NULL
noticed	NULL
after	NULL
a	NULL
short	NULL
period	NULL
of	NULL
preincubation	NULL
.	NULL
``	NULL

Human	NULL
monocytes	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-4	NULL
for	NULL
5	NULL
hours	NULL
and	NULL
subsequently	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
288	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
Northern	NULL
hybridization	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
IL-4	NULL
lowered	NULL
the	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
.	NULL

After	NULL
30	NULL
minutes	NULL
of	NULL
LPS	NULL
activation	NULL
,	NULL
both	NULL
the	NULL
c-fos	NULL
and	NULL
the	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
was	NULL
decreased	NULL
approximately	NULL
twofold	NULL
to	NULL
threefold	NULL
.	NULL

Proto-oncogene	NULL
mRNA	NULL
expression	NULL
returned	NULL
to	NULL
baseline	NULL
levels	NULL
after	NULL
60	NULL
to	NULL
120	NULL
minutes	NULL
of	NULL
LPS	NULL
treatment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
kinetics	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
were	NULL
not	NULL
changed	NULL
by	NULL
IL-4	NULL
,	NULL
neither	NULL
did	NULL
IL-4	NULL
by	NULL
itself	NULL
induce	NULL
c-fos	NULL
or	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
was	NULL
related	NULL
to	NULL
a	NULL
change	NULL
in	NULL
the	NULL
LPS-binding	NULL
properties	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
induced	NULL
by	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
.	NULL

``	NULL
``	NULL
*	NULL
IL-4	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
A23187-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
with	NULL
a	NULL
factor	NULL
of	NULL
2	NULL
to	NULL
3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Run-on	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
involves	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
(	NULL
control	NULL
)	NULL
,	NULL
IL-4	NULL
for	NULL
3	NULL
hours	NULL
,	NULL
LPS	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
3	NULL
hours	NULL
)	NULL
plus	NULL
LPS	NULL
(	NULL
10	NULL
minutes	NULL
)	NULL
.	NULL

Nuclear	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
pBR322	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
288	NULL
DNAs	NULL
.	NULL

Several	NULL
run-on	NULL
experiments	NULL
using	NULL
un-stimulated	NULL
cells	NULL
from	NULL
different	NULL
donors	NULL
showed	NULL
great	NULL
variability	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
avoid	NULL
the	NULL
problem	NULL
of	NULL
donor	NULL
to	NULL
donor	NULL
vari-ability	NULL
,	NULL
monocyte	NULL
nuclei	NULL
of	NULL
four	NULL
donors	NULL
were	NULL
pooled	NULL
before	NULL
the	NULL
run-on	NULL
reaction	NULL
was	NULL
started	NULL
.	NULL

Control	NULL
cells	NULL
demonstrated	NULL
a	NULL
constitutive	NULL
transcription	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
the	NULL
c-jun	NULL
genes	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
both	NULL
control	NULL
cells	NULL
and	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
IL-4	NULL
strongly	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
gene	NULL
(	NULL
approximately	NULL
threefold	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
transcriptional	NULL
mechanisms	NULL
mediate	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-4	NULL
INHIBITS	NULL
PROTO-ONCOGENE	NULL
EXPRESSION	NULL
15	NULL
30	NULL
min	NULL
min	NULL
--	NULL
--	NULL
--	NULL
39	NULL
_J	NULL
O	NULL
CC	NULL
i.-42	NULL
i	NULL
i	NULL
mn	NULL
G	NULL
A.	NULL
a	NULL
a	NULL
-	NULL
a	NULL
U	NULL
_J	NULL
md	NULL
mud	NULL
Pte	NULL
I	NULL
IL-4	NULL
pre-treatment	NULL
-	NULL
_-	NULL
+	NULL
-	NULL
+	NULL
a	NULL
f	NULL
¥	NULL
c_fos	NULL
*	NULL
‘	NULL
a	NULL
ﬂ	NULL
.	NULL

lick	NULL
-	NULL
e	NULL
c-jun	NULL
#	NULL
#	NULL
#	NULL
288	NULL
Fig	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
total	NULL
monocyte	NULL
RNA	NULL
extracted	NULL
after	NULL
incubation	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
16	NULL
hours	NULL
(	NULL
control	NULL
)	NULL
,	NULL
after	NULL
activation	NULL
with	NULL
1	NULL
g/mL	NULL
LPS	NULL
for	NULL
15	NULL
and	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
after	NULL
a	NULL
5-hour	NULL
treatment	NULL
with	NULL
IL-4	NULL
(	NULL
15	NULL
ng/mL	NULL
)	NULL
and	NULL
subsequent	NULL
activation	NULL
with	NULL
1	NULL
ug/mL	NULL
LPS	NULL
for	NULL
15	NULL
and	NULL
30	NULL
minutes	NULL
.	NULL

The	NULL
transcript	NULL
size	NULL
for	NULL
c-fos	NULL
is	NULL
2.2	NULL
kb	NULL
and	NULL
for	NULL
c-jun	NULL
2.7	NULL
kb	NULL
for	NULL
the	NULL
major	NULL
transcript	NULL
and	NULL
3.2	NULL
kb	NULL
for	NULL
the	NULL
minor	NULL
transcript	NULL
.	NULL

The	NULL
28	NULL
$	NULL
signal	NULL
demonstrates	NULL
equal	NULL
gel	NULL
loading	NULL
.	NULL

The	NULL
result	NULL
is	NULL
one	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
.	NULL

IL-4	NULL
on	NULL
proto-oncogene	NULL
mRNA	NULL
expression	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
5	NULL
or	NULL
20	NULL
minutes	NULL
with	NULL
LPS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
posttranscriptional	NULL
mechanisms	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
by	NULL
IL-4	NULL
,	NULL
the	NULL
stability	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNAs	NULL
was	NULL
studied	NULL
.	NULL

First	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
in	NULL
uninduced	NULL
monocytes	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
the	NULL
cells	NULL
with	NULL
ActD	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
both	NULL
transcripts	NULL
in	NULL
uninduced	NULL
cells	NULL
is	NULL
approximately	NULL
25	NULL
minutes	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
as	NULL
determined	NULL
by	NULL
densito-metric	NULL
scanning	NULL
and	NULL
normalization	NULL
of	NULL
the	NULL
signals	NULL
to	NULL
the	NULL
respective	NULL
28S	NULL
signal	NULL
.	NULL

Upon	NULL
activation	NULL
with	NULL
LPS	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNAs	NULL
were	NULL
slightly	NULL
stabilized	NULL
and	NULL
decayed	NULL
with	NULL
half-lives	NULL
of	NULL
approximately	NULL
35	NULL
and	NULL
45	NULL
minutes	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

A	NULL
5-hour	NULL
pretreatment	NULL
with	NULL
IL-4	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
data	NULL
consistently	NULL
show	NULL
an	NULL
initial	NULL
stabilization	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNAs	NULL
within	NULL
the	NULL
first	NULL
15	NULL
minutes	NULL
.	NULL

In	NULL
two	NULL
additional	NULL
experiments	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
.	NULL

Thus	NULL
,	NULL
IL-4	NULL
does	NULL
not	NULL
modulate	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
at	NULL
the	NULL
posttranscriptional	NULL
level	NULL
.	NULL

To	NULL
study	NULL
whether	NULL
these	NULL
mRNA	NULL
data	NULL
reflect	NULL
changes	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
we	NULL
performed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

339	NULL
To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
LPS-induced	NULL
expression	NULL
of	NULL
AP-1	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
control	NULL
cells	NULL
and	NULL
IL-4-	NULL
and	NULL
LPS-stimulated	NULL
cells	NULL
and	NULL
monocytes	NULL
that	NULL
were	NULL
pretreated	NULL
with	NULL
IL-4	NULL
and	NULL
subsequently	NULL
activated	NULL
with	NULL
LPS	NULL
.	NULL

Nuclei	NULL
of	NULL
five	NULL
donors	NULL
were	NULL
pooled	NULL
before	NULL
the	NULL
extraction	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
AP-1	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
LPS-stimulated	NULL
monocytes	NULL
expressed	NULL
AP-1	NULL
protein	NULL
that	NULL
was	NULL
suppressed	NULL
by	NULL
pretreatment	NULL
with	NULL
IL-4	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
specifically	NULL
competed	NULL
by	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
nonlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
site	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
specific	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
IL-4	NULL
inhibits	NULL
LPS-induced	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-Jun	NULL
mRNA	NULL
and	NULL
AP-1	NULL
levels	NULL
in	NULL
human	NULL
adherent	NULL
monocytes	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-4	NULL
was	NULL
mediated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
by	NULL
downregulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
was	NULL
observed	NULL
that	NULL
,	NULL
despite	NULL
the	NULL
relatively	NULL
high	NULL
c-fos	NULL
transcription	NULL
rate	NULL
in	NULL
uninduced	NULL
monocytes	NULL
,	NULL
low	NULL
amounts	NULL
of	NULL
c-fos	NULL
mRNA	NULL
were	NULL
detected	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
an	NULL
elongation	NULL
block	NULL
upstream	NULL
from	NULL
exon	NULL
3	NULL
,	NULL
as	NULL
described	NULL
for	NULL
the	NULL
c	NULL
fos	NULL
gene	NULL
in	NULL
murine	NULL
and	NULL
hamster	NULL
macrophages	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
However	NULL
,	NULL
Sariban	NULL
et	NULL
al	NULL
``	NULL
``	NULL
showed	NULL
that	NULL
in	NULL
resting	NULL
human	NULL
monocytes	NULL
CONTROL	NULL
IL-4	NULL
+LPS	NULL
IL-4	NULL
LPS	NULL
pBR322	NULL
c-fos	NULL
.	NULL

<	NULL
p	NULL
.	NULL

#	NULL
.	NULL

%	NULL
»	NULL
c-jun	NULL
#	NULL
285	NULL
QJQ	NULL
‘	NULL
.	NULL

Fig	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
.	NULL

Nuclei	NULL
were	NULL
prepared	NULL
from	NULL
human	NULL
monocytes	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
(	NULL
control	NULL
)	NULL
,	NULL
IL-4	NULL
for	NULL
5	NULL
hours	NULL
,	NULL
LPS	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
or	NULL
IL-4	NULL
for	NULL
5	NULL
hours	NULL
and	NULL
,	NULL
subsequently	NULL
,	NULL
LPS	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Transcription	NULL
in	NULL
the	NULL
isolated	NULL
nuclei	NULL
was	NULL
analyzed	NULL
by	NULL
hybridization	NULL
of	NULL
the	NULL
°2P	NULL
transcripts	NULL
to	NULL
5	NULL
ug	NULL
of	NULL
linearized	NULL
plasmids	NULL
containing	NULL
no	NULL
insert	NULL
(	NULL
pBR322	NULL
)	NULL
and	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
28	NULL
$	NULL
cDNA	NULL
inserts	NULL
immobilized	NULL
on	NULL
nylon	NULL
membranes	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
run-on	NULL
assays	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

340	NULL
DOKTER	NULL
ET	NULL
AL	NULL
IL-L+	NULL
--	NULL
CONTROL	NULL
Act	NULL
0	NULL
(	NULL
min	NULL
)	NULL
0	NULL
15	NULL
30	NULL
45	NULL
c-fos	NULL
#	NULL
#	NULL
c-jun	NULL
288	NULL
140	NULL
7	NULL
A	NULL
120	NULL
4	NULL
€	NULL
100	NULL
7	NULL
0	NULL
,	NULL
3	NULL
CC	NULL
E	NULL
$	NULL
+	NULL
E	NULL
e	NULL
é	NULL
``	NULL
40	NULL
{	NULL
*	NULL
o	NULL
&	NULL
20	NULL
poon	NULL
o	NULL
yon	NULL
aot	NULL
¥	NULL
T	NULL
15	NULL
30	NULL
45	NULL
60	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
@	NULL
#	NULL
»	NULL
LPS	NULL
[	NULL
LPS	NULL
--	NULL
15	NULL
30	NULL
45	NULL
0	NULL
15	NULL
30	NULL
45	NULL
®t	NULL
#	NULL
an	NULL
140	NULL
7	NULL
120	NULL
-	NULL
oa	NULL
g	NULL
100	NULL
3	NULL
[	NULL
+4	NULL
E	NULL
®	NULL
84	NULL
E	NULL
-	NULL
v	NULL
E	NULL
60	NULL
-	NULL
A\	NULL
g	NULL
o	NULL
40	NULL
4	NULL
o	NULL
A	NULL
zo	NULL
-	NULL
\	NULL
.	NULL

T	NULL
T	NULL
Copes	NULL
15	NULL
30	NULL
45	NULL
60	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
LPS	NULL
and	NULL
IL-4	NULL
plus	NULL
LPS	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Monocytes	NULL
were	NULL
cultured	NULL
with	NULL
medium	NULL
(	NULL
no	NULL
treatment	NULL
;	NULL
control	NULL
}	NULL
,	NULL
LPS	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
IL-4	NULL
for	NULL
5	NULL
hours	NULL
and	NULL
,	NULL
subsequently	NULL
,	NULL
LPS	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
10	NULL
was	NULL
then	NULL
added	NULL
to	NULL
inhibit	NULL
transcription	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
at	NULL
various	NULL
time	NULL
points	NULL
(	NULL
indicated	NULL
)	NULL
after	NULL
actinomycin	NULL
D	NULL
admission	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Percentage	NULL
change	NULL
of	NULL
c-fos	NULL
mRNA	NULL
accumulation	NULL
in	NULL
time	NULL
normalized	NULL
to	NULL
the	NULL
28S	NULL
signal	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Control	NULL
cells	NULL
;	NULL
(	NULL
0	NULL
)	NULL
LPS	NULL
(	NULL
30	NULL
minutes	NULL
)	NULL
-treated	NULL
monocytes	NULL
;	NULL
(	NULL
a	NULL
)	NULL
IL-4	NULL
(	NULL
5	NULL
hours	NULL
)	NULL
plus	NULL
LPS	NULL
(	NULL
30	NULL
minutes	NULL
)	NULL
-treated	NULL
monocytes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Percentage	NULL
change	NULL
of	NULL
c-jun	NULL
mRNA	NULL
accumulation	NULL
in	NULL
time	NULL
normalized	NULL
to	NULL
the	NULL
28S	NULL
signal	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Control	NULL
cells	NULL
;	NULL
(	NULL
0	NULL
)	NULL
LPS	NULL
(	NULL
30	NULL
minutes	NULL
}	NULL
)	NULL
-treated	NULL
monocytes	NULL
;	NULL
(	NULL
a	NULL
)	NULL
IL-4	NULL
(	NULL
5	NULL
hours	NULL
)	NULL
plus	NULL
LPS	NULL
(	NULL
30	NULL
minutes	NULL
)	NULL
-treated	NULL
monocytes	NULL
.	NULL

transcription	NULL
of	NULL
the	NULL
first	NULL
two	NULL
exons	NULL
and	NULL
the	NULL
last	NULL
two	NULL
exons	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
occurred	NULL
at	NULL
a	NULL
similar	NULL
rate	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
low	NULL
amounts	NULL
of	NULL
c-fos	NULL
mRNA	NULL
must	NULL
be	NULL
ascribed	NULL
to	NULL
the	NULL
instability	NULL
of	NULL
the	NULL
c-fos	NULL
transcript	NULL
.	NULL

Moreover	NULL
,	NULL
they	NULL
demonstrated	NULL
a	NULL
threefold	NULL
increased	NULL
c-fos	NULL
transcription	NULL
rate	NULL
upon	NULL
a	NULL
20-minute	NULL
TPA	NULL
treatment	NULL
.	NULL

Our	NULL
nuclear	NULL
run-on	NULL
experiment	NULL
did	NULL
not	NULL
show	NULL
LPS-induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-Jun	NULL
genes	NULL
after	NULL
5	NULL
,	NULL
10	NULL
,	NULL
or	NULL
20	NULL
minutes	NULL
of	NULL
LPS	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
these	NULL
genes	NULL
was	NULL
enhanced	NULL
by	NULL
LPS	NULL
.	NULL

The	NULL
experimental	NULL
procedure	NULL
for	NULL
isolating	NULL
nuclei	NULL
requires	NULL
at	NULL
least	NULL
20	NULL
minutes	NULL
in	NULL
which	NULL
we	NULL
might	NULL
have	NULL
missed	NULL
the	NULL
peak	NULL
in	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
is	NULL
further	NULL
underscored	NULL
by	NULL
the	NULL
mRNA	NULL
stability	NULL
studies	NULL
,	NULL
which	NULL
showed	NULL
only	NULL
a	NULL
small	NULL
initial	NULL
stabilization	NULL
of	NULL
oncogene	NULL
mRNA	NULL
within	NULL
the	NULL
first	NULL
15	NULL
minutes	NULL
after	NULL
LPS	NULL
treatment	NULL
.	NULL

The	NULL
small	NULL
increase	NULL
in	NULL
mRNA	NULL
stability	NULL
seems	NULL
inade-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-4	NULL
INHIBITS	NULL
PROTO-ONCOGENE	NULL
EXPRESSION	NULL
CONTROL	NULL
IL-4	NULL
+LPS	NULL
LPS	NULL
LPS	NULL
LPS	NULL
EXTRACT	NULL
:	NULL
NON	NULL
SELF	NULL
100	NULL
%	NULL
SELF	NULL
100	NULL
x	NULL
COMPETITOR	NULL
:	NULL
-	NULL
_	NULL
my	NULL
-	NULL
=	NULL
FREE	NULL
PROBE	NULL
<	NULL
=	NULL
>	NULL
Fig	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
LPS-induced	NULL
expression	NULL
of	NULL
AP-1	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
LPS-induced	NULL
AP-1	NULL
binding	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
control	NULL
monocytes	NULL
,	NULL
from	NULL
monocytes	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
ug/mL	NULL
LPS	NULL
for	NULL
4	NULL
hours	NULL
,	NULL
and	NULL
from	NULL
monocytes	NULL
that	NULL
were	NULL
treated	NULL
for	NULL
5	NULL
hours	NULL
with	NULL
15	NULL
ng/mL	NULL
IL-4	NULL
and	NULL
were	NULL
subsequently	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
LPS	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
*°P-labeled	NULL
19-bp	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AP-1	NULL
target	NULL
sequence	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
100	NULL
x	NULL
molar	NULL
excess	NULL
of	NULL
nonlabeled	NULL
self	NULL
and	NULL
nonself	NULL
oligonucleotides	NULL
.	NULL

The	NULL
nonself	NULL
oligonucleotide	NULL
is	NULL
a	NULL
20-mer	NULL
spanning	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
site	NULL
and	NULL
its	NULL
structure	NULL
is	NULL
given	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Duplicate	NULL
experiments	NULL
with	NULL
other	NULL
batches	NULL
showed	NULL
similar	NULL
results	NULL
.	NULL

quate	NULL
to	NULL
explain	NULL
the	NULL
large	NULL
accumulation	NULL
of	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
.	NULL

Half-lives	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNAs	NULL
were	NULL
similar	NULL
to	NULL
half-lives	NULL
of	NULL
c-jun	NULL
transcripts	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells*	NULL
``	NULL
and	NULL
c-fos	NULL
transcripts	NULL
in	NULL
TPA-treated	NULL
human	NULL
monocytes	NULL
.	NULL
``	NULL

IL-4	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
stability	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
.	NULL

Control	NULL
of	NULL
stability	NULL
of	NULL
mRNA	NULL
is	NULL
poorly	NULL
understood	NULL
,	NULL
but	NULL
the	NULL
process	NULL
likely	NULL
involves	NULL
factors	NULL
interacting	NULL
with	NULL
mRNA	NULL
sequences	NULL
.	NULL

**	NULL
``	NULL
The	NULL
AU-rich	NULL
motifs	NULL
in	NULL
the	NULL
3	NULL
'	NULL
noncoding	NULL
region	NULL
of	NULL
many	NULL
short-living	NULL
mRNAs	NULL
are	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
target	NULL
of	NULL
a	NULL
pathway	NULL
for	NULL
mRNA	NULL
degradation	NULL
and	NULL
an	NULL
AUUUA-specific	NULL
mRNA-binding	NULL
protein	NULL
has	NULL
been	NULL
identi-fied	NULL
.	NULL

***	NULL
``	NULL
Both	NULL
the	NULL
c-jun	NULL
and	NULL
the	NULL
c-fos	NULL
transcripts	NULL
share	NULL
these	NULL
AU-rich	NULL
sequences	NULL
in	NULL
their	NULL
3	NULL
'	NULL
noncoding	NULL
regions	NULL
,	NULL
which	NULL
might	NULL
explain	NULL
the	NULL
high	NULL
turnover	NULL
rate	NULL
of	NULL
these	NULL
However	NULL
,	NULL
Shyu	NULL
et	NULL
al	NULL
``	NULL
``	NULL
demonstrated	NULL
that	NULL
the	NULL
instability	NULL
of	NULL
the	NULL
c-fos	NULL
transcript	NULL
is	NULL
not	NULL
merely	NULL
mediated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
AU	NULL
341	NULL
rich	NULL
motif	NULL
.	NULL

They	NULL
observed	NULL
that	NULL
the	NULL
primary	NULL
pathway	NULL
for	NULL
c	NULL
fos	NULL
mRNA	NULL
decay	NULL
is	NULL
degradation	NULL
mediated	NULL
by	NULL
a	NULL
determinant	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
c-fos	NULL
mRNA	NULL
.	NULL
``	NULL

To	NULL
demonstrate	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
mRNA	NULL
results	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
and	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
AP-1	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
formed	NULL
by	NULL
the	NULL
protein	NULL
products	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-Jun	NULL
genes	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
mRNA	NULL
results	NULL
,	NULL
IL-4	NULL
was	NULL
shown	NULL
to	NULL
lower	NULL
the	NULL
levels	NULL
of	NULL
LPS-induced	NULL
AP-1	NULL
.	NULL

We	NULL
``	NULL
and	NULL
others®	NULL
'	NULL
``	NULL
``	NULL
*	NULL
``	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
IL-4	NULL
inhibits	NULL
expression	NULL
of	NULL
TNFa	NULL
,	NULL
IL-1	NULL
,	NULL
G-CSF	NULL
,	NULL
and	NULL
IL-6	NULL
.	NULL

Furthermore	NULL
,	NULL
LPS-induced	NULL
IL-1	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
IL-4	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL
``	NULL

}	NULL
The	NULL
promoter	NULL
regions	NULL
of	NULL
these	NULL
genes	NULL
all	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
about	NULL
IL-4-induced	NULL
AP-1	NULL
inhibition	NULL
as	NULL
being	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
inhibits	NULL
cytokine	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
several	NULL
studies	NULL
demonstrated	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
activating	NULL
transcription	NULL
factor	NULL
(	NULL
ATF	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
factor	NULL
IL-6	NULL
(	NULL
NF-IL6	NULL
)	NULL
are	NULL
also	NULL
of	NULL
importance	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Studies	NULL
addressing	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
currently	NULL
un-derway	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-4	NULL
inhibits	NULL
the	NULL
LPS-induced	NULL
c-fos	NULL
and	NULL
c-/ur	NULL
mRNA	NULL
accumulation	NULL
as	NULL
well	NULL
as	NULL
AP-1	NULL
levels	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
transcriptional	NULL
mechanisms	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
P.	NULL
Trotta	NULL
for	NULL
his	NULL
generous	NULL
gift	NULL
of	NULL
IL-4	NULL
and	NULL
Dr	NULL
R.	NULL
Henschler	NULL
for	NULL
providing	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
probes	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Paul	NULL
WE	NULL
:	NULL
Interleukin-4	NULL
:	NULL
A	NULL
prototypic	NULL
immunoregulatory	NULL
lym-phokine	NULL
.	NULL

Blood	NULL
77:1859	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Yokata	NULL
T	NULL
,	NULL
Otsuka	NULL
T	NULL
,	NULL
Mosmann	NULL
T	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
interleukin	NULL
cDNA	NULL
clone	NULL
,	NULL
homologous	NULL
to	NULL
mouse	NULL
B-cell	NULL
stimulatory	NULL
factor	NULL
1	NULL
,	NULL
that	NULL
expresses	NULL
B-cell	NULL
and	NULL
T-cell	NULL
stimulating	NULL
ac-tivities	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:5894	NULL
,	NULL
1986	NULL
3	NULL
.	NULL

Brown	NULL
MA	NULL
,	NULL
Pierce	NULL
JH	NULL
,	NULL
Watson	NULL
CJ	NULL
,	NULL
Falco	NULL
J	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Paul	NULL
WE	NULL
:	NULL
B-cell	NULL
stimulatory	NULL
factor-1/IL-4	NULL
mRNA	NULL
is	NULL
expressed	NULL
by	NULL
normal	NULL
and	NULL
transformed	NULL
mast	NULL
cells	NULL
.	NULL

Cell	NULL
50:809	NULL
,	NULL
1987	NULL
4	NULL
.	NULL

Te	NULL
Velde	NULL
AA	NULL
,	NULL
Klomp	NULL
JPG	NULL
,	NULL
Yard	NULL
BA	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
,	NULL
Figdor	NULL
CG	NULL
:	NULL
Modulation	NULL
of	NULL
phenotypic	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
by	NULL
IL-4	NULL
.	NULL

J	NULL
Immunol	NULL
140:1548	NULL
,	NULL
1988	NULL
5	NULL
.	NULL

Broxmeyer	NULL
HE	NULL
,	NULL
Lu	NULL
L	NULL
,	NULL
Cooper	NULL
S	NULL
,	NULL
Rubin	NULL
BY	NULL
,	NULL
Gillis	NULL
S	NULL
,	NULL
Williams	NULL
DE	NULL
:	NULL
Synergistic	NULL
effects	NULL
of	NULL
purified	NULL
recombinant	NULL
human	NULL
and	NULL
murine	NULL
B-cell	NULL
growth	NULL
factor/IL-4	NULL
on	NULL
colony	NULL
formation	NULL
in	NULL
vitro	NULL
by	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
141:3852	NULL
,	NULL
1988	NULL
6	NULL
.	NULL

Vellenga	NULL
E	NULL
,	NULL
de	NULL
Wolf	NULL
JThM	NULL
,	NULL
Beentjes	NULL
JAM	NULL
,	NULL
Esselink	NULL
MT	NULL
,	NULL
Smit	NULL
JW	NULL
,	NULL
Halie	NULL
MR	NULL
:	NULL
Divergent	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
G-CSF	NULL
and	NULL
IL-3	NULL
supported	NULL
myeloid	NULL
colony	NULL
formation	NULL
from	NULL
normal	NULL
and	NULL
leukemic	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Blood	NULL
75:633	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Wolf	NULL
de	NULL
JThM	NULL
,	NULL
Beentjes	NULL
JAM	NULL
,	NULL
Esselink	NULL
MT	NULL
,	NULL
Smit	NULL
JW	NULL
,	NULL
Halie	NULL
MR	NULL
,	NULL
Vellenga	NULL
E	NULL
:	NULL
IL-4	NULL
suppresses	NULL
the	NULL
IL-3	NULL
dependent	NULL
erythroid	NULL
colony	NULL
formation	NULL
from	NULL
normal	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
74:246	NULL
,	NULL
1990	NULL
8	NULL
.	NULL

Sonada	NULL
Y	NULL
,	NULL
Okuda	NULL
T	NULL
,	NULL
Yokota	NULL
T	NULL
,	NULL
Meakawa	NULL
T	NULL
,	NULL
Shizumi	NULL
Y	NULL
,	NULL
Ni-shigaki	NULL
H	NULL
,	NULL
Misawa	NULL
S	NULL
,	NULL
Fujii	NULL
H	NULL
,	NULL
Abe	NULL
T	NULL
:	NULL
Actions	NULL
of	NULL
human	NULL
interleukin-4/B-cell	NULL
stimulatory	NULL
factor-1	NULL
on	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
enriched	NULL
hematopoietic	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

Blood	NULL
75:1615	NULL
,	NULL
1990	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

342	NULL
9	NULL
.	NULL

Hart	NULL
PH	NULL
,	NULL
Vitti	NULL
GF	NULL
,	NULL
Burgess	NULL
DR	NULL
,	NULL
Whitty	NULL
GA	NULL
,	NULL
Piccoli	NULL
DS	NULL
,	NULL
Hamilton	NULL
JA	NULL
:	NULL
Potential	NULL
anti-inflammatory	NULL
effects	NULL
of	NULL
interleukin-4	NULL
:	NULL
Suppression	NULL
of	NULL
human	NULL
monocyte	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
interleukin-1	NULL
and	NULL
prostaglandin	NULL
E	NULL
;	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:3803	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Essner	NULL
R	NULL
,	NULL
Rhoades	NULL
K	NULL
,	NULL
McBridge	NULL
WH	NULL
,	NULL
Morton	NULL
DL	NULL
,	NULL
Economou	NULL
JS	NULL
:	NULL
;	NULL
IL-4	NULL
down	NULL
regulates	NULL
IL-1	NULL
and	NULL
TNF	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
142:3857	NULL
,	NULL
1989	NULL
11	NULL
.	NULL

Vellenga	NULL
E	NULL
,	NULL
Dokter	NULL
W	NULL
,	NULL
De	NULL
Wolf	NULL
JThM	NULL
,	NULL
Van	NULL
de	NULL
Vinne	NULL
B	NULL
,	NULL
Esselink	NULL
MT	NULL
,	NULL
Halie	NULL
MR	NULL
:	NULL
Interleukin-4	NULL
prevents	NULL
the	NULL
induction	NULL
of	NULL
G-CSF	NULL
mRNA	NULL
in	NULL
human	NULL
adherent	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
endotoxin	NULL
and	NULL
IL-1	NULL
stimulation	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
79:22	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Te	NULL
Velde	NULL
AA	NULL
,	NULL
Huijbens	NULL
RJF	NULL
,	NULL
Heije	NULL
K	NULL
,	NULL
Vries	NULL
de	NULL
JE	NULL
,	NULL
Figdor	NULL
CG	NULL
:	NULL
Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
inhibits	NULL
secretion	NULL
of	NULL
IL-18	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
and	NULL
IL-6	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
76:1392	NULL
,	NULL
1990	NULL
13	NULL
.	NULL

Donnelly	NULL
RP	NULL
,	NULL
Fenton	NULL
MJ	NULL
,	NULL
Kaufman	NULL
JD	NULL
,	NULL
Gerrard	NULL
TL	NULL
:	NULL
IL-1	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
is	NULL
transcriptionally	NULL
and	NULL
posttran-scriptionally	NULL
regulated	NULL
by	NULL
IL-4	NULL
.	NULL

J	NULL
Immunol	NULL
146:3431	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Chiu	NULL
R	NULL
,	NULL
Boyle	NULL
WJ	NULL
,	NULL
Meek	NULL
J	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Hunter	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
The	NULL
Fos	NULL
protein	NULL
interacts	NULL
with	NULL
c-jun/AP-1	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
AP-1	NULL
responsive	NULL
genes	NULL
.	NULL

Cell	NULL
54:541	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Curran	NULL
T	NULL
,	NULL
Franza	NULL
BR	NULL
Jr	NULL
:	NULL
Fos	NULL
and	NULL
Jun	NULL
:	NULL
The	NULL
AP-1	NULL
connection	NULL
.	NULL

Cell	NULL
55:395	NULL
,	NULL
1988	NULL
16	NULL
.	NULL

Nakabeppu	NULL
Y	NULL
,	NULL
Ryder	NULL
K	NULL
,	NULL
Nathans	NULL
D	NULL
:	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
three	NULL
murine	NULL
jun	NULL
proteins	NULL
:	NULL
Stimulation	NULL
by	NULL
Fos	NULL
.	NULL

Cell	NULL
55:907	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Halazonetis	NULL
TD	NULL
,	NULL
Georgopoulos	NULL
K	NULL
,	NULL
Greenberg	NULL
ME	NULL
,	NULL
Leder	NULL
P	NULL
:	NULL
c-jun	NULL
dimerizes	NULL
with	NULL
itself	NULL
and	NULL
with	NULL
c-fos	NULL
,	NULL
forming	NULL
complexes	NULL
of	NULL
different	NULL
DNA	NULL
binding	NULL
affinities	NULL
.	NULL

Cell	NULL
55:917	NULL
,	NULL
1988	NULL
18	NULL
.	NULL

Kouzarides	NULL
T	NULL
,	NULL
Ziff	NULL
E	NULL
:	NULL
The	NULL
role	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
in	NULL
the	NULL
fos-jun	NULL
interaction	NULL
.	NULL

Nature	NULL
336:646	NULL
,	NULL
1988	NULL
19	NULL
.	NULL

Sassone-Corsi	NULL
P	NULL
,	NULL
Ransone	NULL
LJ	NULL
,	NULL
Lamph	NULL
WW	NULL
,	NULL
Verma	NULL
IM	NULL
:	NULL
Direct	NULL
interaction	NULL
between	NULL
fos	NULL
and	NULL
jun	NULL
nuclear	NULL
oncoproteins	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
'leucine	NULL
zipper	NULL
'	NULL
domain	NULL
.	NULL

Nature	NULL
336:692	NULL
,	NULL
1988	NULL
20	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Imagawa	NULL
M	NULL
,	NULL
Chiu	NULL
R	NULL
,	NULL
Stein	NULL
B	NULL
,	NULL
Imbra	NULL
RJ	NULL
,	NULL
Rahmsdorf	NULL
HJ	NULL
,	NULL
Jonat	NULL
C	NULL
,	NULL
Herrlich	NULL
P	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA	NULL
modulated	NULL
transacting	NULL
factor	NULL
.	NULL

Cell	NULL
49:729	NULL
,	NULL
1987	NULL
21	NULL
.	NULL

Lee	NULL
W	NULL
,	NULL
Mitchell	NULL
P	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741	NULL
,	NULL
1987	NULL
22	NULL
.	NULL

Chiu	NULL
R	NULL
,	NULL
Imagawa	NULL
M	NULL
,	NULL
Imbra	NULL
RJ	NULL
,	NULL
Bockoven	NULL
JR	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Multiple	NULL
cis-	NULL
and	NULL
trans-acting	NULL
elements	NULL
mediate	NULL
the	NULL
transcriptional	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
.	NULL

Nature	NULL
329:648	NULL
,	NULL
1987	NULL
23	NULL
.	NULL

Imagawa	NULL
M	NULL
,	NULL
Chiu	NULL
R	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
pathways	NULL
:	NULL
Protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
51:251	NULL
,	NULL
1987	NULL
24	NULL
.	NULL

Vellenga	NULL
E	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Ernst	NULL
TJ	NULL
,	NULL
Ostapoviez	NULL
D	NULL
,	NULL
Griffin	NULL
JD	NULL
:	NULL
Independent	NULL
regulation	NULL
of	NULL
the	NULL
M-CSF	NULL
and	NULL
G-CSF	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
71:1529	NULL
,	NULL
1988	NULL
25	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
of	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
26	NULL
.	NULL

Curran	NULL
T	NULL
,	NULL
MacConnel	NULL
WP	NULL
,	NULL
Straaten	NULL
van	NULL
F	NULL
,	NULL
Verma	NULL
IM	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
FBJ	NULL
murine	NULL
osteosarcoma	NULL
virus	NULL
genome	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
its	NULL
associated	NULL
helper	NULL
virus	NULL
and	NULL
the	NULL
cellular	NULL
homolog	NULL
of	NULL
the	NULL
v-fos	NULL
gene	NULL
from	NULL
mouse	NULL
and	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
3:914	NULL
,	NULL
1983	NULL
27	NULL
.	NULL

Miller	NULL
AD	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Verma	NULL
IM	NULL
:	NULL
c-fos	NULL
protein	NULL
can	NULL
induce	NULL
cellular	NULL
transformation	NULL
:	NULL
A	NULL
novel	NULL
mechanism	NULL
of	NULL
activation	NULL
of	NULL
a	NULL
cellular	NULL
oncogene	NULL
.	NULL

Cell	NULL
36:51	NULL
,	NULL
1984	NULL
28	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Allegretto	NULL
EA	NULL
,	NULL
Okino	NULL
ST	NULL
,	NULL
Hattori	NULL
K	NULL
,	NULL
Boyle	NULL
WJ	NULL
,	NULL
Hunter	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
332:166	NULL
,	NULL
1988	NULL
29	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Miiller	NULL
MM	NULL
,	NULL
Schaffner	NULL
W	NULL
:	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini	NULL
extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:6419	NULL
,	NULL
1989	NULL
DOKTER	NULL
ET	NULL
AL	NULL
30	NULL
.	NULL

Atchison	NULL
M	NULL
,	NULL
Perry	NULL
R	NULL
:	NULL
The	NULL
role	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
its	NULL
binding	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
developmental	NULL
regulation	NULL
of	NULL
x	NULL
gene	NULL
transcription	NULL
.	NULL

Cell	NULL
48:121	NULL
,	NULL
1987	NULL
31	NULL
.	NULL

Clark	NULL
L	NULL
,	NULL
Hay	NULL
R	NULL
:	NULL
Sequence	NULL
requirement	NULL
for	NULL
specific	NULL
interaction	NULL
of	NULL
an	NULL
enhancer	NULL
binding	NULL
protein	NULL
(	NULL
EBPI1	NULL
)	NULL
with	NULL
DNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:499	NULL
,	NULL
1989	NULL
32	NULL
.	NULL

Muller	NULL
R	NULL
,	NULL
Muller	NULL
D	NULL
,	NULL
Guilbert	NULL
L	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
c-fos	NULL
in	NULL
hematopoietic	NULL
cells	NULL
;	NULL
Correlation	NULL
with	NULL
differentiation	NULL
of	NULL
monomyelocytic	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

EMBO	NULL
J	NULL
3:1887	NULL
,	NULL
1984	NULL
33	NULL
.	NULL

Muller	NULL
R	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Muller	NULL
D	NULL
,	NULL
Guilbert	NULL
L	NULL
:	NULL
Induction	NULL
of	NULL
c-fos	NULL
during	NULL
myelomonocytic	NULL
differentiation	NULL
and	NULL
macrophage	NULL
proliferation	NULL
.	NULL

Nature	NULL
314:546	NULL
,	NULL
1985	NULL
34	NULL
.	NULL

Introna	NULL
M	NULL
,	NULL
Hamilton	NULL
TA	NULL
,	NULL
Kaufman	NULL
RE	NULL
,	NULL
Adams	NULL
DO	NULL
,	NULL
Bast	NULL
RC	NULL
Jr	NULL
:	NULL
Treatment	NULL
of	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
with	NULL
bacterial	NULL
lipopolysaccharide	NULL
alters	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-myc	NULL
oncogenes	NULL
.	NULL

J	NULL
Immunol	NULL
137:2711	NULL
,	NULL
1986	NULL
35	NULL
.	NULL

Sariban	NULL
E	NULL
,	NULL
Luebbers	NULL
R	NULL
,	NULL
Kufe	NULL
D	NULL
:	NULL
Transcriptional	NULL
and	NULL
posttranscriptional	NULL
control	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:340	NULL
,	NULL
1988	NULL
36	NULL
.	NULL

Haskill	NULL
S	NULL
,	NULL
Johnson	NULL
C	NULL
,	NULL
Eierman	NULL
D	NULL
,	NULL
Becker	NULL
S	NULL
,	NULL
Warren	NULL
K	NULL
:	NULL
Adherence	NULL
induces	NULL
selective	NULL
mRNA	NULL
expression	NULL
of	NULL
monocyte	NULL
mediators	NULL
and	NULL
proto-oncogenes	NULL
.	NULL

J	NULL
Immunol	NULL
140:1690	NULL
,	NULL
1988	NULL
37	NULL
.	NULL

Radzioch	NULL
D	NULL
,	NULL
Bottazzi	NULL
D	NULL
,	NULL
Varesio	NULL
L	NULL
:	NULL
Augmentation	NULL
of	NULL
c-fos	NULL
mRNA	NULL
expression	NULL
by	NULL
activators	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
fresh	NULL
,	NULL
terminally	NULL
differentiated	NULL
resting	NULL
monocytes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
7:595	NULL
,	NULL
1987	NULL
38	NULL
.	NULL

Bravo	NULL
R	NULL
,	NULL
Neuberg	NULL
M	NULL
,	NULL
Burckhardt	NULL
J	NULL
,	NULL
Almendral	NULL
J	NULL
,	NULL
Wallich	NULL
R	NULL
,	NULL
Muller	NULL
R	NULL
:	NULL
Involvement	NULL
of	NULL
common	NULL
and	NULL
cell	NULL
type-specific	NULL
pathways	NULL
in	NULL
c-fos	NULL
gene	NULL
control	NULL
:	NULL
Stable	NULL
induction	NULL
of	NULL
cAMP	NULL
in	NULL
macrophages	NULL
.	NULL

Cell	NULL
48:251	NULL
,	NULL
1987	NULL
39	NULL
.	NULL

Fort	NULL
P	NULL
,	NULL
Rech	NULL
J	NULL
,	NULL
Vie	NULL
A	NULL
,	NULL
Piechaczyk	NULL
M	NULL
,	NULL
Bonnieu	NULL
A	NULL
,	NULL
Jeanteur	NULL
P	NULL
,	NULL
Blanchard	NULL
JM	NULL
:	NULL
Regulation	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
in	NULL
hamster	NULL
fibroblasts	NULL
:	NULL
Initiation	NULL
and	NULL
elongation	NULL
of	NULL
transcription	NULL
and	NULL
mRNA	NULL
degradation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
15:5657	NULL
,	NULL
1987	NULL
40	NULL
.	NULL

Collart	NULL
MA	NULL
,	NULL
Tourkine	NULL
N	NULL
,	NULL
Belin	NULL
D	NULL
,	NULL
Vassalli	NULL
P	NULL
,	NULL
Jeanteur	NULL
P	NULL
,	NULL
Blanchard	NULL
JM	NULL
:	NULL
c-fos	NULL
gene	NULL
transcription	NULL
in	NULL
murine	NULL
macrophages	NULL
is	NULL
modulated	NULL
by	NULL
a	NULL
calcium-dependent	NULL
block	NULL
to	NULL
elongation	NULL
in	NULL
intron	NULL
1	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:2826	NULL
,	NULL
1991	NULL
41	NULL
.	NULL

Sherman	NULL
ML	NULL
,	NULL
Stone	NULL
RM	NULL
,	NULL
Datta	NULL
R	NULL
,	NULL
Bernstein	NULL
SH	NULL
,	NULL
Kufe	NULL
DW	NULL
:	NULL
Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:3320	NULL
,	NULL
1990	NULL
42	NULL
.	NULL

Brawerman	NULL
G	NULL
:	NULL
Determinants	NULL
of	NULL
messenger	NULL
RNA	NULL
stability	NULL
.	NULL

Cell	NULL
48:5	NULL
,	NULL
1987	NULL
43	NULL
.	NULL

Brawerman	NULL
G	NULL
:	NULL
mRNA	NULL
decay	NULL
:	NULL
Finding	NULL
the	NULL
right	NULL
targets	NULL
.	NULL

Cell	NULL
57:9	NULL
,	NULL
1989	NULL
44	NULL
.	NULL

Shaw	NULL
G	NULL
,	NULL
Kamen	NULL
R	NULL
:	NULL
A	NULL
conserved	NULL
AU	NULL
sequence	NULL
from	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
mediates	NULL
selective	NULL
mRNA	NULL
degradation	NULL
.	NULL

Cell	NULL
46:659	NULL
,	NULL
1986	NULL
45	NULL
.	NULL

Malter	NULL
JS	NULL
:	NULL
Identification	NULL
of	NULL
an	NULL
AUUUA-specific	NULL
messenger	NULL
RNA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
246:664	NULL
,	NULL
1989	NULL
46	NULL
.	NULL

Shyu	NULL
AB	NULL
,	NULL
Greenberg	NULL
ME	NULL
,	NULL
Belasco	NULL
JG	NULL
:	NULL
The	NULL
c-fos	NULL
transcript	NULL
is	NULL
targeted	NULL
for	NULL
rapid	NULL
decay	NULL
by	NULL
two	NULL
distinct	NULL
mRNA	NULL
degradation	NULL
pathways	NULL
.	NULL

Genes	NULL
Dev	NULL
3:60	NULL
,	NULL
1989	NULL
47	NULL
.	NULL

Ray	NULL
A	NULL
,	NULL
Sassone-Corsi	NULL
P	NULL
,	NULL
Seghal	NULL
PB	NULL
:	NULL
A	NULL
multiple	NULL
cytokine-	NULL
and	NULL
second	NULL
messenger-responsive	NULL
element	NULL
in	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
human	NULL
interleukin-6	NULL
gene	NULL
:	NULL
Similarities	NULL
with	NULL
c-fos	NULL
gene	NULL
regulation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
6:5537	NULL
,	NULL
1989	NULL
48	NULL
.	NULL

Nishizawa	NULL
M	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Regulatory	NULL
elements	NULL
responsible	NULL
for	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
granulocyte-colony	NULL
stimulating	NULL
factor	NULL
gene	NULL
in	NULL
macrophages	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2002	NULL
,	NULL
1990	NULL
49	NULL
.	NULL

Shimizu	NULL
H	NULL
,	NULL
Mitomo	NULL
K	NULL
,	NULL
Watanabe	NULL
T	NULL
,	NULL
Okamoto	NULL
S	NULL
,	NULL
Yamamoto	NULL
K-I	NULL
:	NULL
Involvement	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-like	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-4	NULL
INHIBITS	NULL
PROTO-ONCOGENE	NULL
EXPRESSION	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
by	NULL
inflammatory	NULL
lymphokines	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:561	NULL
,	NULL
1990	NULL
50	NULL
.	NULL

Nishizawa	NULL
M	NULL
,	NULL
Tsuchiya	NULL
M	NULL
,	NULL
Watanabe	NULL
FR	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Multiple	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
regulate	NULL
its	NULL
constitutive	NULL
expression	NULL
in	NULL
human	NULL
carcinoma	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:5897	NULL
,	NULL
1990	NULL
51	NULL
.	NULL

Isshiki	NULL
H	NULL
,	NULL
Akira	NULL
S	NULL
,	NULL
Tanabe	NULL
O	NULL
,	NULL
Nakajima	NULL
T	NULL
,	NULL
Shimamoto	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Constitutive	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
-in-ducible	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
IL-1-responsive	NULL
element	NULL
in	NULL
the	NULL
IL-6	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2757	NULL
,	NULL
1990	NULL
52	NULL
.	NULL

Akira	NULL
S	NULL
,	NULL
Isshiki	NULL
H	NULL
,	NULL
Sugati	NULL
T	NULL
,	NULL
Tanabe	NULL
O	NULL
,	NULL
Kinoshita	NULL
S	NULL
,	NULL
Nishio	NULL
Y	NULL
,	NULL
Nakajima	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
9	NULL
:	NULL
1897	NULL
,	NULL
1990	NULL
343	NULL
53	NULL
.	NULL

Goldfeld	NULL
AE	NULL
,	NULL
Doyle	NULL
C	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:9769	NULL
,	NULL
1990	NULL
54	NULL
.	NULL

Collart	NULL
MA	NULL
,	NULL
Bacuerle	NULL
P	NULL
,	NULL
Vassalli	NULL
P	NULL
:	NULL
Regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
Involvement	NULL
of	NULL
four	NULL
xB-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:1498	NULL
,	NULL
1990	NULL
55	NULL
.	NULL

Shakov	NULL
AN	NULL
,	NULL
Collart	NULL
MA	NULL
,	NULL
Vassalli	NULL
P	NULL
,	NULL
Nedospasov	NULL
SA	NULL
,	NULL
Jongeneel	NULL
CV	NULL
:	NULL
«	NULL
B-type	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
171:35	NULL
,	NULL
1990	NULL
56	NULL
.	NULL

Kinoshita	NULL
S	NULL
,	NULL
Akira	NULL
S	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
A	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
,	NULL
NF-IL6	NULL
$	NULL
,	NULL
forms	NULL
a	NULL
heterodimer	NULL
and	NULL
transcriptionally	NULL
synergizes	NULL
with	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:1473	NULL
,	NULL
1992	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blO	NULL
Od®	NULL
1993	NULL
81	NULL
:	NULL
337-343	NULL
Interleukin-4	NULL
inhibits	NULL
the	NULL
lipopolysaccharide-induced	NULL
expression	NULL
of	NULL
c	NULL
jun	NULL
and	NULL
c-fos	NULL
messenger	NULL
RNA	NULL
and	NULL
activator	NULL
protein-1	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
s	NULL
A	NULL
al	NULL
4	NULL
fol	NULL
8	NULL
%	NULL
A	NULL
_	NULL
gs	NULL
%	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
0	NULL
;	NULL
2108	NULL
WH	NULL
Dokter	NULL
,	NULL
MT	NULL
Esselink	NULL
,	NULL
MR	NULL
Halie	NULL
and	NULL
E	NULL
Vellenga	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/81/2/337.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

